Pharmaceuticals
Enabling quick and smart access to Pharmaceuticals ingredients, we bring API expertise with a worldwide sourcing, and have a certified Excipients experience. Either you are looking for Veterinary API’s, Human API’s, Excipients, API Impurities, you can find them quickly by browsing our online catalog.
Pharmaceuticals
5
results for
Pharmaceuticals
Filters
Refine your search
Oxytetracycline hydrochloride developed for pharmaceutical
applications. It is suitable for oral dosage forms.Benefits:
- Meets with EP and USP specifications
TDS
Oxytetracycline dihydrate designed for pharmaceutical
applications. It is suitable for injectable forms.Benefits:
- Meets with EP and USP specifications
- FDA certified
TDS
Oxytetracycline hydrochloride designed for pharmaceutical
applications. It is suitable for injections. Shelf life: 3 years.Benefits:
- Meets with EP 10 specifications
TDS
API developed for pharmaceutical applications. It is semi-synthetic
penicillin. It is used to treat bacterial infections.Benefits:
- Extra dry grade
- Available in crystalline powder and granule
- Complies with EP
- Meets with DMF and CEP No. R1-CEP 2012-078-Rev 01
TDS
API suitable for pharmaceutical applications. It is semi-synthetic
penicillin. It is used to treat bacterial infections.Benefits:
- N, N-Dimethyaniline-free
- Complies with EP
- Meets with DMF and CEP No. R1-CEP 2012-078-Rev 01
TDS
Dc Pharma
Hebei Shengxue Dacheng Pharmaceuticat Co., Ltd founded in 1997, is a large pharmaceutical company focusing on producing and marketing antibiotics, feed additives and premixes. Our company is state owned and subordinate to China National Nuclear Corporation. We set up two wholly-owned subsidiaries - Hebei Shengxue Dacheng Pharmaceutical (Tangshan) Co., Ltd and Hebei Hongcheng Yaxin Technology Co.,Ltd.
Zhuhai United Laboratories
Founded in Hong Kong in 1990, The United Laboratories(TUL) is operating for over two decades, now TUL is positioned as one of the largest antibiotic pharmaceutical companies in the world. Considering that 100% of its capital is owned by Hong Kong Shareholders, TUL is currently structured into three Divisions: API and Intermediate Production, Biopharmaceutical products, Production formulation.
